$5.24 Billion is the total value of Matrix Capital Management Company, LP's 17 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 42.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | GLOBALFOUNDRIES INCordinary shares | $996,857,220 | +18.3% | 18,498,000 | +6.1% | 19.03% | +18.1% | |
| NVDA | Buy | NVIDIA CORPORATION | $741,368,220 | +239.3% | 5,073,000 | +181.8% | 14.15% | +238.6% |
| TDG | TRANSDIGM GROUP INC | $689,403,785 | +20.0% | 1,094,900 | 0.0% | 13.16% | +19.7% | |
| ALTR | Buy | ALTAIR ENGR INC | $494,304,370 | +8.5% | 10,871,000 | +5.5% | 9.44% | +8.3% |
| AMZN | Buy | AMAZON COM INC | $427,140,000 | -5.6% | 5,085,000 | +27.0% | 8.15% | -5.8% |
| AMAT | Buy | APPLIED MATLS INC | $415,715,220 | +31.3% | 4,269,000 | +10.5% | 7.94% | +31.1% |
| QCOM | QUALCOMM INC | $366,909,358 | -2.7% | 3,337,360 | 0.0% | 7.00% | -2.9% | |
| ASML | Buy | ASML HOLDING N V | $271,670,080 | +109.4% | 497,200 | +59.2% | 5.19% | +108.9% |
| WDAY | Buy | WORKDAY INCcl a | $265,392,575 | +55.5% | 1,586,043 | +41.5% | 5.07% | +55.2% |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $185,287,456 | -7.0% | 9,199,973 | 0.0% | 3.54% | -7.2% | |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $88,414,588 | +7.3% | 11,572,590 | 0.0% | 1.69% | +7.1% | |
| ZS | Buy | ZSCALER INC | $72,735,000 | +16.8% | 650,000 | +71.6% | 1.39% | +16.6% |
| PERIMETER SOLUTIONS SA | $68,207,250 | +14.1% | 7,462,500 | 0.0% | 1.30% | +13.9% | ||
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $56,902,310 | +35.8% | 38,974,185 | 0.0% | 1.09% | +35.6% | |
| Buy | AURA BIOSCIENCES INC | $56,310,135 | -24.4% | 5,362,870 | +30.4% | 1.08% | -24.6% | |
| XLE | New | SELECT SECTOR SPDR TRenergy | $30,562,018 | – | 349,400 | +100.0% | 0.58% | – |
| VENTYX BIOSCIENCES INC | $10,984,650 | -6.1% | 335,000 | 0.0% | 0.21% | -6.2% | ||
| TXG | Exit | 10X GENOMICS INC | $0 | – | -60,000 | -100.0% | -0.03% | – |
| ADCT | Exit | ADC THERAPEUTICS SA | $0 | – | -400,000 | -100.0% | -0.04% | – |
| ZI | Exit | ZOOMINFO TECHNOLOGIES INC | $0 | – | -116,000 | -100.0% | -0.09% | – |
| Exit | IMAGO BIOSCIENCES INC | $0 | – | -361,000 | -100.0% | -0.10% | – | |
| U | Exit | UNITY SOFTWARE INC | $0 | – | -258,000 | -100.0% | -0.16% | – |
| NET | Exit | CLOUDFLARE INC | $0 | – | -160,000 | -100.0% | -0.17% | – |
| CRM | Exit | SALESFORCE INC | $0 | – | -316,500 | -100.0% | -0.87% | – |
| MU | Exit | MICRON TECHNOLOGY INC | $0 | – | -4,000,000 | -100.0% | -3.83% | – |
| TWLO | Exit | TWILIO INCcl a | $0 | – | -5,588,749 | -100.0% | -7.39% | – |
| CRWD | Exit | CROWDSTRIKE HLDGS INCcl a | $0 | – | -3,000,000 | -100.0% | -9.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSDIGM GROUP INC | 42 | Q3 2023 | 13.3% |
| WORKDAY INC | 42 | Q3 2023 | 19.7% |
| NETFLIX INC | 37 | Q2 2022 | 26.1% |
| NEW RELIC INC | 29 | Q1 2022 | 7.8% |
| DAVITA INC | 26 | Q3 2019 | 6.1% |
| ADAPTIMMUNE THERAPEUTICS PLC | 26 | Q3 2023 | 6.8% |
| SALESFORCE INC | 23 | Q3 2022 | 18.4% |
| CONSTELLATION BRANDS INC | 23 | Q2 2019 | 5.7% |
| AMAZON COM INC | 21 | Q3 2023 | 11.2% |
| TABLEAU SOFTWARE INC | 20 | Q2 2019 | 15.2% |
View Matrix Capital Management Company, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | July 10, 2023 | 233,845,110 | 17.3% |
| Zentalis Pharmaceuticals, Inc. | June 20, 2023 | 13,959,973 | 19.8% |
| ForgeRock, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| NEW RELIC, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Perimeter Solutions, SA | February 13, 2023 | 8,587,500 | 5.4% |
| Aura Biosciences, Inc. | December 07, 2022 | 5,362,870 | 14.5% |
| Adaptive Biotechnologies Corp | February 14, 2022 | 11,572,590 | 8.2% |
| BigCommerce Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| CarGurus, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Trillium Therapeutics Inc.Sold out | February 14, 2020 | 0 | 0.0% |
View Matrix Capital Management Company, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-11-09 |
| SC 13D/A | 2023-11-09 |
| 13F-HR | 2023-08-14 |
| SC 13G/A | 2023-07-10 |
| 4 | 2023-06-20 |
| SC 13D/A | 2023-06-20 |
| 13F-HR | 2023-05-15 |
View Matrix Capital Management Company, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.